Cancer neoantigens and immunogenicity: mutation position matters
Cancer mutations can elicit protective immunity. Computational methods are critical for selecting these neoantigens for immunotherapy. While significant progress has been made in the field in predicting peptide presentation, our understanding of which mutated peptide is recognized as foreign by T ce...
| Published in: | Molecular & Cellular Oncology |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2020-05-01
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/23723556.2020.1740071 |